Nanotech regulation
This article was originally published in The Rose Sheet
Executive Summary
A new report commissioned by the Project on Emerging Nanotechnologies (PEN) at the Woodrow Wilson International Center for Scholars stresses the need for regulatory oversight of nanotechnology and provides a "roadmap" for the Environmental Protection Agency to handle the challenges of the science. In the report, author J. Clarence Davies lays out an agenda designed to create an "effective oversight system" to "minimize any adverse effects of nano-materials," identifying a need for change within the EPA in areas of science, program integration, personnel, international activities and program evaluation, according to a May 23 release. The 76-page report outlines 25 steps that EPA, the government, the U.S. National Nanotechnology Initiative and the nanotechnology industry should take to improve oversight. "This new report seeks to encourage ... an intelligent oversight approach that empowers EPA and promotes investment and innovation in new nanotechnology products and processes," states PEN Director David Rejeski...
You may also be interested in...
Commercialization Phase Brings New Challenges To Nanotech Industry
Increased industry/government collaboration is needed in the field of nanotechnology to move from the research & development phase to the comercialization phase, speakers told the President's Council of Advisors on Science and Technology (PCAST) during a June 25 meeting in Arlington, Va
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.